The invention relates to methods of treating viral infections, and in particular hepatitis B virus. The method comprises administering to a subject in need of such treatment an infection-controlling amount of a phospholipid or phospholipid derivative to inhibit the activity of the viral infection.

 
Web www.patentalert.com

> Fusion protein construct and method for inducing HIV-specific serum IgG and secretory IgA antibodies in-vivo

~ 00390